Are serum leptin levels a prognostic factor in advanced lung cancer? - PubMed
Are serum leptin levels a prognostic factor in advanced lung cancer?
C Anar et al. Bratisl Lek Listy. 2017.
Abstract
Aim: The aim of the present study was to evaluate pre-treatment concentrations of leptin in patients with advanced lung cancer and to investigate possible associations between their levels and clinicopathological variables, response to therapy and overall survival.
Material and methods: There are 71 previously untreated patients with cytological or histological evidence of primary lung cancer who were admitted to the oncology department between November 2013 and August 2014. Forty-five healthy individuals with age, sex and BMI matching the lung cancer patients, were recruited to take part in the study as a control group. Leptin levels were measured quantitatively by using a microELISA kit.
Results: The serum leptin levels at diagnosis were significantly lower in lung cancer patients than those in control subjects (4.75±4.91 ng/ml, 9.67±8.02 ng/ml; p<0.001). We did not find any significant difference in leptin values related to clinicopathological parameters such as ECOG PS, weight loss, histological type, disease stage and TNM classification. Nevertheless, we demonstrated a significant correlation between serum leptin levels and BMI in lung cancer patients (correlation coefficient: 0.303; p>0.010). The analysis of serum leptin values did not show any association with the overall survival of the patients.
Conclusion: Our results showed that the serum leptin level has no prognostic indications in advanced lung cancer patients. Leptin is decreased in lung cancer, and there is lack of correlation with tumour‑related factors including prognosis. Therefore, leptin is not a useful clinical marker in lung cancer (Tab. 2, Fig. 2, Ref. 22).
Keywords: leptin; survival prognosis..
Similar articles
-
Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
Tas F, Duranyildiz D, Argon A, Oğuz H, Camlica H, Yasasever V, Topuz E. Tas F, et al. Med Oncol. 2005;22(4):353-8. doi: 10.1385/MO:22:4:353. Med Oncol. 2005. PMID: 16260852
-
Clinical significance of serum adipokines levels in lung cancer.
Kerenidi T, Lada M, Tsaroucha A, Georgoulias P, Mystridou P, Gourgoulianis KI. Kerenidi T, et al. Med Oncol. 2013 Jun;30(2):507. doi: 10.1007/s12032-013-0507-x. Epub 2013 Feb 22. Med Oncol. 2013. PMID: 23430445
-
The value of serum Bcl-2 levels in advanced lung cancer patients.
Tas F, Duranyildiz D, Oguz H, Camlica H, Oral EN, Yasasever V, Topuz E. Tas F, et al. Med Oncol. 2005;22(2):139-43. doi: 10.1385/MO:22:2:139. Med Oncol. 2005. PMID: 15965276
-
Karapanagiotou EM, Tsochatzis EA, Dilana KD, Tourkantonis I, Gratsias I, Syrigos KN. Karapanagiotou EM, et al. Lung Cancer. 2008 Sep;61(3):391-7. doi: 10.1016/j.lungcan.2008.01.018. Epub 2008 Mar 14. Lung Cancer. 2008. PMID: 18342391
-
Metastin is not involved in metastatic potential of non-small cell lung cancer.
Karapanagiotou EM, Dilana KD, Gkiozos I, Gratsias I, Tsimpoukis S, Polyzos A, Syrigos KN. Karapanagiotou EM, et al. Med Oncol. 2011 Jun;28(2):559-64. doi: 10.1007/s12032-010-9466-7. Epub 2010 Mar 6. Med Oncol. 2011. PMID: 20213218
Cited by
-
Haddad B, Khalil J, Al Khashali H, Ray R, Goel S, Darweesh B, Coleman KL, Wozniak C, Ranzenberger R, Lopo B, Guthrie J, Heyl D, Evans HG. Haddad B, et al. Sci Rep. 2024 Feb 28;14(1):4921. doi: 10.1038/s41598-024-55717-y. Sci Rep. 2024. PMID: 38418632 Free PMC article.
-
Leptin: A Heavyweight Player in Obesity-Related Cancers.
Caruso A, Gelsomino L, Panza S, Accattatis FM, Naimo GD, Barone I, Giordano C, Catalano S, Andò S. Caruso A, et al. Biomolecules. 2023 Jul 6;13(7):1084. doi: 10.3390/biom13071084. Biomolecules. 2023. PMID: 37509120 Free PMC article. Review.
-
Xu M, Cao FL, Li N, Gao X, Su X, Jiang X. Xu M, et al. Oncol Lett. 2018 Oct;16(4):4782-4788. doi: 10.3892/ol.2018.9230. Epub 2018 Jul 30. Oncol Lett. 2018. PMID: 30250542 Free PMC article.
-
Wang J, Zhou F, Li F, Wang B, Hu Y, Li X. Wang J, et al. Ann Transl Med. 2021 Apr;9(7):568. doi: 10.21037/atm-20-7482. Ann Transl Med. 2021. PMID: 33987266 Free PMC article.
-
Nishio M, Atagi S, Goto K, Hosomi Y, Seto T, Hida T, Nakagawa K, Yoshioka H, Nogami N, Maemondo M, Nagase S, Okamoto I, Yamamoto N, Igawa Y, Tajima K, Fukuoka M, Yamamoto N, Nishio K. Nishio M, et al. Transl Lung Cancer Res. 2023 Jun 30;12(6):1167-1184. doi: 10.21037/tlcr-22-632. Epub 2023 Jun 13. Transl Lung Cancer Res. 2023. PMID: 37425411 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical